Human Mutation · 1998 · 18 citations · 16 references
Life SciencesGeneticsMolecular GeneticsClinical ImmunologyImmunogeneticsPediatric ImmunologyCombined ImmunodeficiencyGenetic DisordersImmune DysfunctionImmunodeficiency DisordersPrimary ImmunodeficiencyPrimary Immunodeficiency GeneticsAdenosine Deaminase DeficiencyCongenital Immunodeficiency DisordersDeletionsGenotype Phenotype RelationshipMissense MutationsMolecular Genetics Of ImmunodeficiencyMutationPrimary Immunodeficiency Disorders
The degree of immunodeficiency associated with deficiency of adenosine deaminase (ADA) is variable. Most patients are infants with severe combined immunodeficiency (SCID), but in about 20 percent immune dysfunction becomes manifest later in childhood ("delayed-onset"); several patients with "late" or "adult" onset of immune dysfunction have been diagnosed at 15–39 years. Over 40 ADA gene mutations have thus far been identified. To better define the genotype-phenotype relationship, we report 7 novel ADA mutations, including 5 missense mutations (G74C, V129M, G140E, R149W, Q199P) and two short deletions (462delG, E337del). These were identifed among 7 patients (3 with SCID and 4 with delayed-onset). A homozygote for 462delG had SCID, whereas patients homozygous or heterozygous for V129M had delayed-onset. Two other delayed-onset patients, one heterozygous for G74C and the other for Q199P, each had a second allele carrying the previously reported "severe" mutation G216R. These findings are consistent with previous observations suggesting that, in general, SCID occurs when both alleles eliminate ADA function, and a milder phenotype when at least one allele can supply a low level of function. Hum Mutat 11:482, 1998. © 1998 Wiley-Liss, Inc.
16
RASMOL: biomolecular graphics for all
Roger A. Sayle · Trends in Biochemical Sciences · 1995 · 2.6K citations
ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITY
E.R. Giblett, JeanneE. Anderson, Flossie Cohen et al. · The Lancet · 1972 · 1.7K citations